p53 Activation in Chronic Radiation-Treated Breast Cancer Cells: Regulation of MDM2/p14ARF

Cancer Research

Volumn 64, Issue 1, 2004, Pages 221-228

  Xia, Liqun ^a   Paik, Aimee ^a   Li, Jian Jian ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; MESSENGER RNA; PROTEIN MDM2; PROTEIN P14; PROTEIN P53; THREONINE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DNA BINDING; DNA MICROARRAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MAMMAL CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; RADIOSENSITIVITY; TIME; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; DOSE FRACTIONATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; KINETICS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RADIATION TOLERANCE; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642453823     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0969     Document Type: Article

References (64)

1. Hill, B. T., Shellard, S. A., Hosking, L. K., Fichtinger-Schepman, A. M., and Bedford, P. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diamminedichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Int. J. Radiat. Oncol. Biol. Phys., 19: 75-83, 1990.
2. Joiner, M. C., Lambin, P., Malaise, E. P., Robson, T., Arrand, J. E., Skov, K. A., and Marples, B. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat. Res., 358: 171-183, 1996.
3. Eichholtz-Wirth, H., and Marx, K. Clonal variability of radiation-induced cisplatin resistant HeLa cells. Anticancer Res., 18: 2989-2991, 1998.
4. Azzam, E. I., de Toledo, S. M., Raaphorst, G. P., and Mitchel, R. E. Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat. Res., 146: 369-373, 1996.
5. Boothman, D. A., Odegaard, E., Yang, C. R., Hosley, K., and Mendonca, M. S. Molecular analyses of adaptive survival responses (ASRs): role of ASRs in radiotherapy. Hum. Exp. Toxicol., 17: 448-453, 1998.
6. Feinendegen, L. E., Bond, V. P., Sondhaus, C. A., and Altman, K. I. Cellular signal adaptation with damage control at low doses versus the predominance of DNA damage at high doses. C. R. Acad. Sci. Ser. III, 322: 245-251, 1999.
7. Feinendegen, L. E. Reactive oxygen species in cell responses to toxic agents. Hum. Exp. Toxicol., 21: 85-90, 2002.
8. Russell, J., Wheldon, T. E., and Stanton, P. A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res., 55: 4915-4921, 1995.
9. Li, Z., Xia, L., Lee, M. L., Khaletskiy, A., Wang, J., Wong, J. Y. C., and Li, J. J. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat. Res., 155: 543-553, 2001.
10. Chen, X., Shen, B., Xia, L., Khaletzkiy, A., Chu, D., Wong, J. Y., and Li, J. J. Activation of nuclear factor κB in radioresistance of TP53-inactive human keratinocytes. Cancer Res., 62: 1213-1221, 2002.
11. Fornace, A. J., Jr., Amundson, S. A., Bittner, M., Myers, T. G., Meltzer, P., Weinsten, J. N., and Trent, J. The complexity of radiation stress responses: analysis by informatics and functional genomics approaches. Gene. Expr., 7: 387-400, 1999.
12. Schmidt-Ullrich, R. K., Contessa, J. N., Dent, P., Mikkelsen, R. B., Valerie, K., Reardon, D. B., Bowers, G., and Lin, P. S. Molecular mechanisms of radiation-induced accelerated repopulation. Radiat. Oncol. Investig., 7: 321-330, 1999.
13. McBride, W. H., Pajonk, F., Chiang, C. S., and Sun, J. R. NF-κB, cytokines, proteasomes, and low-dose radiation exposure. Mil. Med., 167: 66-67, 2002.
14. Li, Z., Khaletskiy, A., Wang, J., Wong, J. Y., Oberley, L. W., and Li, J. J. Genes regulated in human breast cancer cells overexpressing manganese-containing super-oxide dismutase. Free Radic. Biol. Med., 30: 260-267, 2001.
15. Guo, G., Yan-Sanders, Y., Lyn-Cook, B. D., Wang, T., Tamae, D., Ogi, J., Khaletskiy, A., Li, Z., Weydert, C., Longmate, J. A., Huang, T. T., Spitz, D. R., Oberley, L. W., and Li, J. J. Manganese superoxide dismutase mediated gene expression in radiation-induced adaptive responses. Mol. Cell. Biol., 23: 2362-2378, 2003.
16. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
17. Giaccia, A. J., and Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12: 2973-2983, 1998.
18. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
19. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
20. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
21. Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C. X., Hanawalt, P. C., and Fornace, A. J., Jr. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell. Biol., 20: 3705-3714, 2000.
22. Tokino, T., Thiagalingam, S., el-Deiry, W. S., Waldman, T., Kinzler, K. W., and Vogelstein, B. p53 tagged sites from human genomic DNA. Hum. Mol. Genet., 3: 1537-1542, 1994.
23. Amundson, S. A., Bittner, M., Chen, Y., Trent, J., Meltzer, P., and Fornace, A. J., Jr. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene, 18: 3666-3672, 1999.
24. Bouvard, V., Zaitchouk, T., Vacher, M., Duthu, A., Canivet, M., Choisy-Rossi, C., Nieruchalski, M., and May, E. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene, 19: 649-660, 2000.
25. Haas-Kogan, D. A., Kogan, S. S., Yount, G., Hsu, J., Haas, M., Deen, D. F., and Israel. M. A. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int. J. Radiat. Oncol. Biol. Phys., 43: 399-403, 1999.
26. Sharpless, N. E., and DePinho, R. A. p53. Good Cop/Bad Cop. Cell, 110: 9-12, 2002.
27. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815-1823, 1994.
28. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
29. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
30. 2 arrest after DNA damage. Science (Wash. DC), 282: 1497-1501, 1998.
31. Ashcroft, M., Taya, Y., and Vousden, K. H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol., 20: 3224-3233, 2000.
32. Lu, W., Pochampally, R., Chen, L., Traidej, M., Wang, Y., and Chen, J. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Oncogene, 19: 232-240, 2000.
33. Gu, J., Nie. L., Wiederschain, D., and Yuan, Z. M. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mol. Cell. Biol., 21: 8533-8546, 2001.
34. Lohrum, M. A., Woods, D. B., Ludwig, R. L., Balint, E., and Vousden, K. H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol., 21: 8521-8532, 2001.
35. Tao, W., and Levine, A. J. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl. Acad. Sci. USA, 96: 6937-6941, 1999.
36. Zhang, Y., and Xiong, Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science (Wash. DC), 292: 1910-1915, 2001.
37. Honda, R., and Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 18: 22-27, 1999.
38. Midgley, C. A., Desterro, J. M., Saville, M. K., Howard, S., Sparks, A., Hay, R. T., and Lane, D. P. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene, 19: 2312-2323, 2000.
39. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature (Lond.), 388: 548-554, 1997.
40. Sun, Y., Dong, Z., Nakamura, K., and Colburn, N. H. Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma. FASEB J., 7: 944-950, 1993.
41. Yu, C. R., Wang, L., Khaletskiy, A., Farrar, W. L., Larner, A., Colburn, N. H., and Li, J. J. Activation of STAT3 in IL-6 induced transformation response in mouse skin epithelial cells. Oncogene, 21: 3940-3960, 2002.
42. Xirodimas, D. P., Chisholm, J., Desterro, J. M., Lane, D. P., and Hay, R. T. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett., 528: 207-211, 2002.
43. Eymin, B., Gazzeri, S., Brambilla, C., and Brambilla, E. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Oncogene, 21: 2750-2761, 2002.
44. 1 arrest and long-term induction of CipI in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
45. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
46. El-Deiry, W. S. Regulation of p53 downstream genes. Semin. Cancer Biol., 8: 345-357, 1998.
47. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
48. Wouters, B. G., Giaccia, A. J., Denko, N. C., and Brown, J. M. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res., 57: 4703-4706, 1997.
49. Amundson, S. A., Do, K. T., and Fornace, A. J., Jr. Induction of stress genes by low doses of γ rays. Radiat. Res., 152: 225-231, 1999.
50. Gu, J., Chen, D., Rosenblum, J., Rubin, R. M., and Yuan, Z. M. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation. Mol. Cell. Biol., 20: 1243-1253, 2000.
51. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin DICDK4. Nature (Lond.), 366: 704-707, 1993.
52. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
53. Zhang, Y., Xiong, Y., and Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92: 725-734, 1998.
54. Vousden, K. H. p53: death star. Cell, 103: 691-694, 2000.
55. Tsang, N. M., Nagasawa, H., Li, C., and Little, J. B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene, 10: 2403-2408, 1995.
56. Couture, C., Raybaud-Diogene, H., Tetu, B., Bairati, I., Murry, D., Allard, J., and Fortin, A. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer (Phila.), 94: 713-722, 2002.
57. Bradbury, C. M., Markovina, S., Wei, S. J., Rene, L. M., Zoberi, I., Horikoshi, N., and Gius, D. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-κB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res., 61: 7689-7696, 2001.
58. Wang, T., Zhang, X., and Li, J. J. The role of NF-κB in the regulation of cell stress responses. Int. Immunopharmacol., 2: 1509-1520, 2002.
59. Ryan, K. M., Ernst, M. K., Rice, N. R., and Vousden, K. H. Role of NF-κB in p53-mediated programmed cell death. Nature (Lond.), 404: 892-897, 2000.
60. Wu, H., and Lozano, G. NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem., 269: 20067-20074, 1994.
61. Yang, C. R., Wilson-Van Patten, C., Planchon, S. M., Wuerzberger-Davis, S. M., Davis, T. W., Cuthill, S., Miyamoto, S., and Boothman, D. A. Coordinate modulation of Sp1, NF-κB, and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB J., 14: 379-390, 2000.
62. Li, G., Nelsen, C., and Hendrickson, E. A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA, 99: 832-837, 2002.
63. Braastad, C. D., Leguia, M., and Hendrickson, E. A. Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element. Nucleic Acids Res., 30: 1713-1724, 2002.
64. Liu, L., Kwak, Y. T., Bex, F., Garcia-Martinez, L. F., Li, X. H., Meek, K., Lane, W. S., and Gaynor, R. B. DNA-dependent protein kinase phosphorylation of IκB α and IκB β regulates NF-κB DNA binding properties. Mol. Cell. Biol., 18: 4221-4234, 1998.